This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Modiblast Pharma GmbH


Modiblast is advancing the clinical development of a new in vivo immunotherapy for currently incurable leukemias (AML and MDS). Our businessmodel is to out-license a first-in-class prefabricated drug for remission maintenance/disease stabilization for the above indications as well as the clinical development of further candidates in the field of immuno-oncology. 

We're bringing you

  • Startup Spotlight Pitch Competition